Blar i HV - Institutt for naturvitenskapelige helsefag på tidsskrift "Epilepsia Open"

Viser treff 1-4 av 4

    • Interactions between antiseizure medications and foods and drinks: A systematic review 

      Asadi-Pooya, Ali A.; Landmark, Cecilie Johannessen; Nafiseh Mirzaei, Damabi; Khatereh, Fazelian (Peer reviewed; Journal article, 2024)
      Antiseizure medications (ASMs) constitute the principal of treatment for patients with epilepsy, where long-term treatment is usually necessary. The purpose of this systematic review is to provide practical and useful ...

    • Refractory epilepsy and nonadherence to drug treatment 

      Henning, Oliver Johannes; Lossius, Morten; Lima, Maren Haugen; Mevåg, Morten Andreas; Villagran, Antonia; Nakken, Karl Otto; Landmark, Cecilie Johannessen (Epilepsia Open;Volume 4, Issue 4,December 2019, Journal article; Peer reviewed, 2019-10-28)
      In patients with epilepsy, nonadherence to agreed antiepileptic drug (AED) treatment may result in seizure relapse, and at worst sudden unexpected death. The aim of this study was to examine the extent of both unintentional ...

    • A retrospective review of changes and challenges in the use ofantiseizure medicines in Dravet syndrome in Norway 

      Lund, Caroline; Burns, Margrete Larsen; Bjørnvold, Marit; Sætre, Erik; Johannessen, Svein Ivar; Landmark, Cecilie Johannessen; Heger, Katrine (Epilepsia Open;Volume 5, Issue 3, September 2020, Journal article; Peer reviewed, 2020-06-26)
      Objective: Dravet syndrome is a developmental and epileptic encephalopathy characterized by severe and drug-resistant seizures in early childhood, followed by developmental delay. The purpose of this study was to investigate ...

    • A survey of the European Reference Network EpiCARE on clinical practice for selected rare epilepsies 

      Baumgartner, Tobias; Carreno, Mar; Rocamora, Rodrigo; Bisulli, Francesca; Boni, Antonella; Brázdil, Milan (Epilepsia Open;volume 6, issue 1, Peer reviewed; Journal article, 2020-12-14)
      Objective: Clinical care of rare and complex epilepsies is challenging, because evidence-based treatment guidelines are scarce, the experience of many physicians is limited, and interdisciplinary treatment of comorbidities ...